Pieris
Hallbergmoos
About Pieris
Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and other medical conditions with unmet medical needs. The company applies its proprietary Anticalin® technology to the drug development processes. Pieris Pharmaceuticals was founded in 2001 and is based in Freising, Bayern.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $18.3M
- Funding stage: IPO
- Last round: Series B (Nov 2006)
- Ticker: fra:PI6
- Website: pieris-ag.com
- Phone: +49 8161 1411400
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/pieris-3516479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.